Utility of the ROX Index in Predicting Intubation for Patients With COVID-19–Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study

BACKGROUND: The use of high-flow nasal therapy (HFNT) to treat COVID-19 pneumonia has been greatly debated around the world due to concerns about increased health care worker transmission and delays in invasive mechanical ventilation (IMV). Herein, we analyzed the utility of the noninvasive ROX (rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Maulin, Chowdhury, Junad, Mills, Nicole, Marron, Robert, Gangemi, Andrew, Dorey-Stein, Zachariah, Yousef, Ibraheem, Zheng, Matthew, Tragesser, Lauren, Giurintano, Julie, Gupta, Rohit, Rali, Parth, D'Alonzo, Gilbert, Zhao, Huaqing, Patlakh, Nicole, Marchetti, Nathaniel, Criner, Gerard, Gordon, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404242/
https://www.ncbi.nlm.nih.gov/pubmed/34548669
http://dx.doi.org/10.2196/29062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404242/
https://www.ncbi.nlm.nih.gov/pubmed/34548669
http://dx.doi.org/10.2196/29062

Ejemplares similares